Total Funding
73
55
Total FundingPost-IPO Equity raised
Growth Score
-19 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
60180
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
- Peter Thompson: Co-Founder and DirectorPast Role: Terremoto Biosciences, CEO and Co-Founder
- Leiv Lea: CFO
About the Company
Corvus is a biopharmaceutical company that develops therapies for immune disorders and cancer, focusing on targeted immune pathway modulation. The company advances a pipeline of investigational treatments while collaborating with partners on additional programs. It works on progressing clinical research and sharing data to support broader advances
in treatment.
